Position in PEN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,781,055
-$4,895,367 QoQ
Shares Held
23,696
-41.9% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $611,097,917 across 24 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
1,622,749 | $126,947,654 | |
| 2 | SYK |
Stryker Corp
|
364,761 | $114,841,353 | |
| 3 | ABT |
Abbott Laboratories
|
1,062,858 | $96,443,734 | |
| 4 | BSX |
Boston Scientific Corp
|
1,325,522 | $56,573,278 | |
| 5 | STE |
STERIS plc
|
217,064 | $45,707,166 | |
| 6 | EW |
Edwards Lifesciences Corp
|
461,098 | $41,710,925 | |
| 7 | BRKR |
Bruker Corp
|
441,505 | $26,569,770 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
82,389 | $24,190,234 |
All Filings in PEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,781,055 | 23,696 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,676,422 | 40,772 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,924,824 | 39,179 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,836,458 | 42,226 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,276,452 | 34,690 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $6,696,461 | 28,198 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $5,387,244 | 27,725 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $3,423,029 | 19,020 | Shares | Defined | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||